Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study
暂无分享,去创建一个
Bradley J. Ferguson | D. Beversdorf | J. Stichter | E. Porges | Janine P. Stichter | Rachel M. Zamzow | Alexandra S Ragsdale | Morgan L. Lewis
[1] ScienceOpen Admin. Advances in Autism , 2017 .
[2] Amanda K Montoya,et al. Two-condition within-participant statistical mediation analysis: A path-analytic framework. , 2017, Psychological methods.
[3] R. Findling,et al. An update on pharmacotherapy for autism spectrum disorder in children and adolescents , 2015, Current opinion in psychiatry.
[4] B. Leiby,et al. Autonomic Dysregulation During Sensory Stimulation in Children with Autism Spectrum Disorder , 2015, Journal of autism and developmental disorders.
[5] Judith S Miller,et al. Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder , 2015, Autism : the international journal of research and practice.
[6] J. Herrington,et al. Brief Report: Emotion Regulation and Respiratory Sinus Arrhythmia in Autism Spectrum Disorder , 2014, Journal of autism and developmental disorders.
[7] Amanda J. Moffitt,et al. Effect of propranolol on facial scanning in autism spectrum disorder: A preliminary investigation , 2014, Journal of clinical and experimental neuropsychology.
[8] R. Bernier,et al. Brief Report: Social Skills, Internalizing and Externalizing Symptoms, and Respiratory Sinus Arrhythmia in Autism , 2014, Journal of autism and developmental disorders.
[9] John O. Willis,et al. Wechsler Abbreviated Scale of Intelligence , 2014 .
[10] M. Bear,et al. STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study , 2013, Journal of Autism and Developmental Disorders.
[11] M. Dadds,et al. Nasal Oxytocin for Social Deficits in Childhood Autism: A Randomized Controlled Trial , 2013, Journal of Autism and Developmental Disorders.
[12] Janet B W Williams. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[13] A. Thurm,et al. Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research , 2013, Drugs.
[14] Angela Scarpa,et al. Respiratory sinus arrhythmia: a marker for positive social functioning and receptive language skills in children with autism spectrum disorders. , 2013, Developmental psychobiology.
[15] J. Stichter,et al. A Preliminary Examination of a General Social Outcome Measure , 2012 .
[16] Kimberly E. Bodner,et al. Noradrenergic Moderation of Working Memory Impairments in Adults with Autism Spectrum Disorder , 2012, Journal of the International Neuropsychological Society.
[17] Gregory F. Lewis,et al. Statistical strategies to quantify respiratory sinus arrhythmia: Are commonly used metrics equivalent? , 2012, Biological Psychology.
[18] Kimberly E. Bodner,et al. Effect of Propranolol on Word Fluency in Autism , 2011, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.
[19] V. Gaus. Adult Asperger Syndrome and the Utility of Cognitive-Behavioral Therapy , 2011, Journal of Contemporary Psychotherapy.
[20] P. Schmalbrock,et al. Effect of Propranolol on Functional Connectivity in Autism Spectrum Disorder—A Pilot Study , 2010, Brain Imaging and Behavior.
[21] S. Porges,et al. Emotion Recognition in Children with Autism Spectrum Disorders: Relations to Eye Gaze and Autonomic State , 2010, Journal of autism and developmental disorders.
[22] D. Beversdorf,et al. Effect of propranolol on verbal problem solving in autism spectrum disorder , 2008, Neurocase.
[23] Keri J. Heilman,et al. Physiological responses to social and physical challenges in children: Quantifying mechanisms supporting social engagement and mobilization behaviors. , 2008, Developmental psychobiology.
[24] Alinda Gillott,et al. Levels of anxiety and sources of stress in adults with autism , 2007, Journal of intellectual disabilities : JOID.
[25] C. Johnson,et al. Management of Children With Autism Spectrum Disorders , 2007, Pediatrics.
[26] M. Dawson,et al. The electrodermal system , 2007 .
[27] Evdokia Anagnostou,et al. Oxytocin Increases Retention of Social Cognition in Autism , 2007, Biological Psychiatry.
[28] C. McDougle,et al. A retrospective study of memantine in children and adolescents with pervasive developmental disorders , 2007, Psychopharmacology.
[29] S. Porges. The polyvagal perspective , 2007, Biological Psychology.
[30] Xue Ming,et al. Reduced cardiac parasympathetic activity in children with autism , 2005, Brain and Development.
[31] Scott Bellini. Social Skill Deficits and Anxiety in High-Functioning Adolescents With Autism Spectrum Disorders , 2004 .
[32] V. Ramachandran,et al. Autonomic responses of autistic children to people and objects , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[33] A. Gillott,et al. Anxiety in High-Functioning Children with Autism , 2001, Autism : the international journal of research and practice.
[34] D. A. Kenny,et al. Estimating and testing mediation and moderation in within-subject designs. , 2001, Psychological methods.
[35] F. Volkmar. Pharmacological Interventions in Autism: Theoretical and Practical Issues , 2001, Journal of clinical child psychology.
[36] P. Rizzon,et al. Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. , 1998, Chest.
[37] S. Spence,et al. A measure of anxiety symptoms among children. , 1998, Behaviour research and therapy.
[38] D. Cohen,et al. Plasma β-endorphin, adrenocorticotropin hormone, and cortisol in autism , 1997 .
[39] M. Hasselmo,et al. Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. , 1997, Journal of neurophysiology.
[40] S. Porges. Cardiac vagal tone: A physiological index of stress , 1995, Neuroscience & Biobehavioral Reviews.
[41] A. Couteur,et al. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.
[42] F. Volkmar,et al. Noradrenergic and adrenergic functioning in autism , 1994, Biological Psychiatry.
[43] J. Cacioppo,et al. Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. , 1993, Psychophysiology.
[44] V. K. Jensen,et al. "The effect of beta blockade on stress-induced cognitive dysfunction in adolescents". , 1991, Clinical pediatrics.
[45] S. Porges,et al. The analysis of periodic processes in psychophysiological research , 1989 .
[46] A. Beck,et al. An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.
[47] M. Lader. Beta-adrenoceptor antagonists in neuropsychiatry: an update. , 1988, The Journal of clinical psychiatry.
[48] J. Bemporad,et al. Brief report: Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults , 1987, Journal of autism and developmental disorders.
[49] J. Fermanian,et al. Catecholamines metabolism in infantile autism: A controlled study of 22 autistic children , 1987, Journal of autism and developmental disorders.
[50] D. Charney,et al. Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity , 1983, Neuropharmacology.
[51] Margaret A. Chesney,et al. Epinephrine and Norepinephrine Responses in Continuously Collected Human Plasma to a Series of Stressors , 1983, Psychosomatic medicine.
[52] D. Murphy,et al. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. , 1977, Archives of general psychiatry.
[53] S. Porges. The vagus: A mediator of behavioral and physiologic features associated with autism. , 2004 .
[54] B. Leventhal,et al. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. , 1990, The Journal of neuropsychiatry and clinical neurosciences.
[55] J. Cacioppo,et al. Principles of psychophysiology : physical, social, and inferential elements , 1990 .
[56] B. Pitt. Psychopharmacology , 1968, Mental Health.